Clinical Trial Update: Chemopreventive Effects of Epigallocatechin Gallate (EGCG) in Colorectal Cancer (CRC) Patients [EARLY_Phase 1]

View source ↗

Summary

Early-phase Phase 1 trial evaluating the chemopreventive effects of epigallocatechin gallate (EGCG) in colorectal cancer patients; the study is currently active…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Epigallocatechin Gallate (epigallocatechin gallate)

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Colon Cancer | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING